Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Abeona Therapeutics (NQ: ABEO )

1.639 USD -0.041 (-2.47%)
Streaming Delayed Price Updated: 12:32 PM EDT, Apr 23, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,173,076
Open 1.770
Bid (Size) 1.630 (175)
Ask (Size) 1.640 (33)
Prev. Close 1.680
Today's Range 1.609 - 1.790
52wk Range 0.9900 - 3.790
Shares Outstanding 98,788,933
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Abeona Therapeutics Announces Presentation on New Preclinical Data Supporting the Potential of Cre-Mediated Dual AAV Vector Technology to Enable Delivery of Large Genes Targeted for Treatment of Starg
From GlobeNewswire News Releases
Abeona Therapeutics Appoints Two Industry Leaders as New Independent Members to Its Board of Directors
New board members add a wealth of experience in clinical development and manufacturing of cell therapy and gene therapy products 
From GlobeNewswire News Releases

Performance

YTD
-3.05%
-3.05%
1 Month
-13.76%
-13.76%
3 Month
-17.25%
-17.25%
6 Month
+29.02%
+29.02%
1 Year
-31.44%
-31.44%

More News

Read More
Abeona Therapeutics Announces Appointment of Two New Independent Members to its Board of Directors
From GlobeNewswire News Releases
Abeona Therapeutics Announces 2020 Financial Results and Recent Operational Progress
From GlobeNewswire News Releases
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Abeona Therapeutics Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
From PR Newswire
Abeona Therapeutics Announces Appointment of Michael Amoroso as Chief Executive Officer
From GlobeNewswire News Releases
Abeona Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare Conference
From GlobeNewswire News Releases
New Positive Phase 1/2 Interim Data Presented at WORLDSymposium™ Shows Neurocognitive Development of Young MPS IIIA Patients Preserved up to Three Years Following Treatment with Abeona’s ABO-102 Gene
From GlobeNewswire News Releases
3 Penny Stocks That Wall Street Wants You To Buy Now
Tags SYBX FBIO Long Ideas
From Benzinga
Thinking about buying stock in Motus GI, Abeona Therapeutics, Skillz Inc, Marker Therapeutics, or Nikola Corp?
From PR Newswire
7 Penny Stocks That May Not Be Penny Stocks For Long
Tags PXLW ABEO NYSE:IO,NASDAQ:FBIO,NASDAQ:PXLW,NASDAQ:CTIC,NASDAQ:SYBX,NASDAQ:EFOI,NASDAQ:ABEO
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.